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Opening the Black Box
Uncovering mechanisms that regulate cell fate determination is a central goal for stem cell biologists. Few examples of cell fate 
alteration are as dramatic as the recent demonstration that terminally differentiated cells can “turn back the clock” and return to 
a pluripotent state after transduction of a few transcription factors. In this issue, Hochedlinger and colleagues reveal intermedi-
ate steps on the path to induced pluripotency, providing additional insights that complement recent findings from the Jaenisch 
laboratory (Brambrink et al., 2:151). The examination of isolated, enriched populations at various stages of reprogramming offers 
windows into what has until now been a “black box” of cellular changes. Another paper in this issue, from Enver and colleagues, 
provides an illustration of a transcription factor role in “forward” fate determination, by showing that MLLT3 is both necessary and 
sufficient for human hematopoietic progenitors to adopt erythrocytic and megakaryocytic lineage fates.
Regulation Varies with Location
Hematopoietic stem cells are often hailed as the “best understood” somatic stem cell, but many 
questions remain unanswered about the function of these blood-forming cells. The roles of 
extrinsic, environmentally localized signals have received considerable attention of late, and two 
reports in this issue examine HSCs in independent sites. The embryonic origin of mammalian 
HSCs has been debated for decades, and has been difficult to pinpoint due to the inherent migra-
tory nature of blood progenitors. By examining embryos with defective circulatory systems, Rho-
des and colleagues establish that primitive blood-forming progenitors arise de novo in the murine 
placenta. In addition, this extraembryonic location appears to offer a supportive environment for 
expansion of blood precursors. Cell cycle of HSCs is tightly regulated and is likely dependent on 
both intrinsic and extrinsic signals. A report from the Scadden laboratory indicates that in adult mice, stem cell longevity is 
affected by the Wnt pathway, and its impact likely is mediated by modulating the cell cycle. Both studies highlight the impor-
tance of assessing HSC activity in the context of the particular environment in which they are located.
Step-by-Step Progress to Therapies
There is little doubt that significant challenges remain before embryonic stem cells achieve their proposed therapeutic potential. 
One such challenge is to unravel the specific developmental pathways that regulate differentiation into specific lineages, in order 
to replicate and manipulate these processes in vitro. Ivey and colleagues make progress toward this goal for cardiomyocytes, 
by revealing that two muscle-specific miRNAs can influence cardiac muscle progenitor development while also repressing gene 
expression profiles of and differentiation into alternate lineages. In addition to identifying mechanisms that can yield abundant, 
purified target populations, effective stem cell therapy will also depend on establishing reliable methods for in vivo cell delivery. 
This issue’s Review from Mooney and Vanderberg discusses the current status of available techniques for transferring stem cells 
and their derivatives to an in vivo setting in a clinically viable manner.
Singing Our Praises
Cell Stem Cell is proud to announce that the Professional and Scholarly Publishing Division of the Associa-
tion of American Publishers has named us the “2007 Best New Journal – Science, Technology & Medicine.” 
It is an honor for the journal and its unique collaboration with the ISSCR to be recognized in this manner. 
We thank all of the contributors, advisors, reviewers, and readers who have helped us earn this mark of 
success so soon after our launch.Cell Stem Cell 2, March 2008 ©2008 Elsevier Inc. xi
